Back to Authors

Jinwal, Umesh K.

Mayo Clinic

USF Health Byrd Alzheimer's Institute

Citations 5

O4‐04‐08: Neuronal tau‐specific stress induction of molecular chaperones: The failure of a coping mechanism
O’Leary, John C., Brady, Sarah, Jinwal, Umesh K., Lewis, Jada , Dickey, Chad A. , Abisambra, Jose F. , Cannon, Ashley , Espinosa, Adriana , Koren, John , Blair, Laura J.

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2011.05.1996 Get It

The Diarylheptanoid (+)-aR,11S-Myricanol and Two Flavones from Bayberry (Myrica cerifera) Destabilize the Microtubule-Associated Protein Tau
Jones, Jeffrey R. , Lebar, Matthew D. , Jinwal, Umesh K., Abisambra, Jose F. , Koren, John , Blair, Laura J. , O’Leary, John C., Davey, Zachary , Trotter, Justin H. , Johnson, Amelia G., Weeber, Edwin J. , Eckman, Christopher B., Baker, Bill J. , Dickey, Chad A.

Journal of Natural Products | December 8, 2010 | Volume: 74 | Issue: 1 | Pages: 38-44

10.1021/np100572z Get It

P3‐425: Chaperone‐mediated modulation of tau aggregation correlates with modifications in tau pathology and synaptic plasticity
Kraft, Clara, Rogers, Justin, Jinwal, Umesh K., Johnson, Amelia G., Jansen‐West, Karen , Banko, Jessica L., Golde, Todd E. , Weeber, Edwin J. , Dickey, Chad A. , Abisambra, Jose F. , Blair, Laura J. , Jones, Jeffrey R. , Hill, Shannon E. , Koren, John , Lawson, Lisa Y. , Muschol, Martin

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_19 | Pages: No page available

10.1016/j.jalz.2010.05.1968 Get It

O1‐06–03: Akt functions to regulate the chaperone complex and attenuate Tau degradation
Dickey, Chad A. , Xu, Yafei , Jinwal, Umesh K., Bailey, Rachel M. , Dunmore, Judith, Morgan, Dave, Petrucelli, Leonard , Koren, John , Zhang, Yong‐Jie , Birnbaum, Morris J.

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_4 | Pages: No page available

10.1016/j.jalz.2008.05.258 Get It

Akt and CHIP coregulate tau degradation through coordinated interactions
Dickey, Chad A. , Koren, John , Zhang, Yong‐Jie , Xu, Ya-Fei, Jinwal, Umesh K., Birnbaum, Morris J. , Monks, Bobby R., Sun, Mei , Cheng, Jin , Patterson, Cam, Bailey, Rachel M. , Dunmore, Judith, Soresh, Sareh, Leon, Carlos M.M.P., Morgan, Dave, Petrucelli, Leonard , Zhang, Yong-Jie

Proceedings of the National Academy of Sciences | February 21, 2008 | Volume: 105 | Issue: 9 | Pages: 3622-3627

10.1073/pnas.0709180105 Get It

A hallmark of the pathology of Alzheimer's disease is the accumulation of the microtubule-associated protein tau into fibrillar aggregates. Recent studies suggest that they accumulate because cytosolic chaperones fail to clear abnormally phosphorylated tau, preserving a pool of toxic tau intermediates within the neuron. We describe a mechanism for tau clearance involving a major cellular kinase, Akt. During stress, Akt is ubiquitinated and degraded by the tau ubiquitin ligase CHIP, and this largely depends on the Hsp90 complex. Akt also prevents CHIP-induced tau ubiquitination and its subsequent degradation, either by regulating the Hsp90/CHIP complex directly or by competing as a client protein with tau for binding. Akt levels tightly regulate the expression of CHIP, such that, as Akt levels are suppressed, CHIP levels also decrease, suggesting a potential stress response feedback mechanism between ligase and kinase activity. We also show that Akt and the microtubule affinity-regulating kinase 2 (PAR1/MARK2), a known tau kinase, interact directly. Akt enhances the activity of PAR1 to promote tau hyperphosphorylation at S262/S356, a tau species that is not recognized by the CHIP/Hsp90 complex. Moreover, Akt1 knockout mice have reduced levels of tau phosphorylated at PAR1/MARK2 consensus sites. Hence, Akt serves as a major regulator of tau biology by manipulating both tau kinases and protein quality control, providing a link to several common pathways that have demonstrated dysfunction in Alzheimer's disease.